Elon Musk's implant research company Neuralink tweeted that it has received approval from the U.S. Food and Drug Administration to launch its 'first-in-human clinical study.'

Neuralink submitted documents to begin human trials of its brain implant, with the goal of allowing disabled people to control technologies with their thoughts.